Eko Murmur Analysis Software (EMAS) vs Rapid PE Triage and Notification (PETN)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by RapidAI (formerly iSchemaView)

AI Verdict

Tool A (Eko Murmur Analysis Software) is an AI tool for detecting and differentiating heart murmurs using digital stethoscope data, primarily aiding in early detection during physical exams. Tool B (Rapid PE Triage and Notification) is an AI-powered software that analyzes CTPA images to rapidly identify suspected central pulmonary embolisms, streamlining workflow in radiology and emergency settings. While both are FDA-cleared AI solutions in cardiology, they address distinct clinical problems using different data modalities and integrate into separate points of care.

Choose Eko Murmur Analysis Software (EMAS) if…

Choose Eko Murmur Analysis Software (EMAS) if your primary need is the early detection and differentiation of heart murmurs during routine physical examinations or follow-up appointments. This tool is ideal for clinicians in primary care, cardiology, or pediatrics who utilize digital stethoscopes and require AI-powered clinical decision support for heart and lung disease screening.

View Eko Murmur Analysis Software (EMAS) →

Choose Rapid PE Triage and Notification (PETN) if…

Choose Rapid PE Triage and Notification (PETN) if your institution requires accelerated identification and notification of suspected central pulmonary embolisms from CTPA images. This AI-powered solution is best suited for emergency departments, critical care units, and radiology departments where rapid diagnosis and streamlined workflow are critical for managing acute PE cases.

View Rapid PE Triage and Notification (PETN) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Murmur Analysis Software (EMAS) Rapid PE Triage and Notification (PETN)
Pricing Free for basic ai analysis with the eko app; paid subscriptions required for full features (eko+) and live streaming telehealth capabilities. Contact for pricing
Deployment Cloud-based service, accessed via mobile application. On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) is accessed via a mobile application and integrates wirelessly with Eko digital stethoscopes, making it highly intuitive for clinicians at the point of care. Its direct interaction with a physical device and mobile interface offers a more immediate and user-friendly experience for individual practitioners. Rapid PE Triage and Notification (PETN) involves a more complex deployment within hospital IT infrastructure, which, while robust for enterprise, may present a steeper initial setup and integration curve.

Clinical Value

Rapid PE Triage and Notification (PETN)

Rapid PE Triage and Notification (PETN) offers immediate, life-saving potential by rapidly identifying suspected central pulmonary embolisms from CTPA images, directly impacting acute care and accelerating treatment pathways for a critical condition. While Eko Murmur Analysis Software (EMAS) provides valuable clinical decision support for early detection of heart and lung disease, PETN's focus on a time-sensitive, life-threatening condition gives it a slight edge in acute clinical impact. Both are FDA-cleared and address important clinical needs.

Pricing & Value

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) offers a free tier for basic AI analysis, making it highly accessible for individual clinicians to explore and utilize. Its transparent, tiered subscription model for additional features provides flexibility and clear value propositions. Rapid PE Triage and Notification (PETN) does not publicly disclose its pricing, indicating an enterprise-level licensing model that likely involves a significant, less transparent investment.

Enterprise Readiness

Rapid PE Triage and Notification (PETN)

Rapid PE Triage and Notification (PETN) demonstrates superior enterprise readiness with its flexible deployment options (on-premise or cloud platform) and deep integration capabilities with PACS, email, and mobile apps for real-time notifications. Its focus on workflow triage and prioritization within acute care settings suggests a more robust and integrated solution for large hospital systems. While Eko Murmur Analysis Software (EMAS) is EHR compatible and HIPAA compliant, PETN's infrastructure and integration points are more geared towards comprehensive enterprise deployment.

Innovation

Rapid PE Triage and Notification (PETN)

Rapid PE Triage and Notification (PETN) represents a significant innovation in acute care by leveraging AI for rapid analysis of complex CTPA images to detect life-threatening pulmonary embolisms and integrate into critical, time-sensitive workflows. This directly impacts triage and notification, potentially reducing time to treatment. Eko Murmur Analysis Software (EMAS) innovates by augmenting traditional auscultation with AI for murmur differentiation, enhancing a common diagnostic method, but PETN's impact on acute, time-critical decision-making is arguably more transformative.

Support & Docs

Rapid PE Triage and Notification (PETN)

Rapid PE Triage and Notification (PETN) offers 24/7/365 customer support via email and phone, which is crucial for a critical enterprise system dealing with life-threatening conditions. Eko Murmur Analysis Software (EMAS) provides a comprehensive help center, user manuals, and scheduled support calls during business hours, with separate resources for enterprise clients. However, the round-the-clock availability of support for PETN is a distinct advantage for an acute care solution.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Murmur Analysis Software (EMAS) Rapid PE Triage and Notification (PETN)
Primary Function FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease. AI-powered software that analyzes CTPA images to rapidly identify and notify clinicians of suspected central pulmonary embolisms, streamlining workflow and accelerating patient care pathways.
Key Data Input Heart sound (PCG) and optional ECG data. CTPA images.
Target Detection/Analysis Detects and differentiates innocent and structural heart murmurs. Detection of suspected central pulmonary embolism (PE).
Specialties Cardiology, Internal Medicine, Pediatrics Cardiology, Emergency Medicine, Radiology
Integration/Connectivity Integrates with Eko digital stethoscopes; Wireless Bluetooth connectivity to mobile devices. Integration within the Rapid Platform; Mobile and desktop application access.

Videos

Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and Rapid PE Triage and Notification (PETN).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Murmur Analysis Software (EMAS) integrates at the point of care during auscultation, providing immediate AI analysis of heart sounds to aid in the early detection and differentiation of murmurs in adult and pediatric patients. This streamlines the initial assessment for conditions requiring further cardiac evaluation. Rapid PE Triage and Notification (PETN) operates in parallel with standard CTPA image review, rapidly identifying suspected central pulmonary embolisms and sending real-time notifications to clinicians. This accelerates triage and care pathways for critical PE cases in emergency and cardiology settings.
EMAS offers PDF report generation and sharing, which is EHR compatible, allowing for documentation of findings within the patient's record. It also enables clinicians to open the Eko dashboard within their EHR for telehealth sessions and push AI analysis results via PDF or an anonymous URL. PETN integrates within the Rapid Platform and sends real-time notifications to clinicians via PACS, email, or mobile app, streamlining communication of critical findings. It also offers automated data collection via EHR integration to track and analyze PE metrics.
EMAS is FDA-cleared AI designed to detect and differentiate innocent and structural heart murmurs, with studies showing sensitivity of 90.0% and specificity of 91.4% for murmurs (excluding grade 1) and 93.2% sensitivity and 86.0% specificity for moderate-to-severe aortic stenosis. PETN demonstrated an overall 94% sensitivity rate and a 93% specificity rate for central PE in a multicenter retrospective study, assisting in rapid risk assessment and care coordination for high-risk PE patients.
EMAS integrates with familiar Eko digital stethoscopes and a mobile app, suggesting a relatively low learning curve for physicians already accustomed to digital auscultation. The intuitive mobile interface facilitates recording, playback, and report generation. PETN operates in parallel with standard of care and primarily provides notifications, indicating a very minimal learning curve for clinicians, with an intuitive interface for reviewing CT scans and chat features.
EMAS allows for recording, saving, and sharing reports, which inherently provides a record of the AI analysis performed and the findings for individual patient encounters. PETN provides real-time notifications and workflow triage, implying a robust logging system for alerts sent, received, and potentially acknowledged by clinicians, supporting tracking of care pathways and accountability.
AI Tool Finder
AI-powered search. Results may not be comprehensive.